Join

Compare · SMLR vs TMDX

SMLR vs TMDX

Side-by-side comparison of Semler Scientific Inc. (SMLR) and TransMedics Group Inc. (TMDX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both SMLR and TMDX operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • TMDX is the larger of the two at $3.41B, about 7.2x SMLR ($470.7M).
  • Over the past year, SMLR is down 37.1% and TMDX is up 7.7% - TMDX leads by 44.8 points.
  • TMDX has hit the wire 6 times in the past 4 weeks while SMLR has been quiet.
  • TMDX has more recent analyst coverage (17 ratings vs 6 for SMLR).
PerformanceSMLR-37.13%TMDX-24.59%
2025-04-30+0.00%2026-01-16
MetricSMLRTMDX
Company
Semler Scientific Inc.
TransMedics Group Inc.
Price
$20.34-5.02%
$98.98+0.43%
Market cap
$470.7M
$3.41B
1M return
+16.67%
-0.40%
1Y return
-37.13%
+7.67%
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
2019
News (4w)
0
6
Recent ratings
6
17
SMLR

Semler Scientific Inc.

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

TMDX

TransMedics Group Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.

Latest SMLR

Latest TMDX